GB930107A - Therapeutic oral preparation of micro-organisms - Google Patents

Therapeutic oral preparation of micro-organisms

Info

Publication number
GB930107A
GB930107A GB912/60A GB91260A GB930107A GB 930107 A GB930107 A GB 930107A GB 912/60 A GB912/60 A GB 912/60A GB 91260 A GB91260 A GB 91260A GB 930107 A GB930107 A GB 930107A
Authority
GB
United Kingdom
Prior art keywords
sugar
lactis
oral preparation
anhydrous
organisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB912/60A
Inventor
Silvano Casadio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GIUSEPPE CARLO SIGURTA
Original Assignee
GIUSEPPE CARLO SIGURTA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GIUSEPPE CARLO SIGURTA filed Critical GIUSEPPE CARLO SIGURTA
Priority to GB912/60A priority Critical patent/GB930107A/en
Publication of GB930107A publication Critical patent/GB930107A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

An oral preparation for the treatment of disorders of the gastro-intestinal tract, consists of a solid stable suspension of any one of the following cultures: Lactobacilli (L. acidophilus, L. casei, L. plantarum, L. helveticus, L. brevis, L. bucheri, L. fermenti, L. bulgaricus, L. bifidus, and L. thermophilus); Streptococci (S. lactis, S. cremoris, S. faecalis, S. liquefaciens, S. zymogenes, S. durans and S. boris); yeasts (Saccharomyces cerevisiae; S. fragilis, S. delbrueckii, S. lactis, S. chevalieri); miscellaneous bacteria (Leuconostoe dextranicum, L. citrororum, Aerobacter aerogenes, Escherichia coli, E. freundii and E. intermedia); in an anhydrous sugar-like medium obtained by heating to 135 DEG to 145 DEG C. glucose, sucrose or corn syrup, or a mixture thereof. The culture is dehydrated by lyophilization or spray drying, mixed with powdered skim milk, lactose or malt extract and dispersed in the above sugar base in an anhydrous plastic condition at 100-110 DEG C., cooling and pressing to form hard candies containing from 100,000 to 50,000,000,000 germs each. The candies may be coated with sugar and then, if desired, with an enteric coating.
GB912/60A 1960-01-11 1960-01-11 Therapeutic oral preparation of micro-organisms Expired GB930107A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB912/60A GB930107A (en) 1960-01-11 1960-01-11 Therapeutic oral preparation of micro-organisms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB912/60A GB930107A (en) 1960-01-11 1960-01-11 Therapeutic oral preparation of micro-organisms

Publications (1)

Publication Number Publication Date
GB930107A true GB930107A (en) 1963-07-03

Family

ID=9712696

Family Applications (1)

Application Number Title Priority Date Filing Date
GB912/60A Expired GB930107A (en) 1960-01-11 1960-01-11 Therapeutic oral preparation of micro-organisms

Country Status (1)

Country Link
GB (1) GB930107A (en)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335107A (en) * 1978-06-05 1982-06-15 Snoeyenbos Glenn H Mixture to protect poultry from salmonella
US4345032A (en) * 1976-05-21 1982-08-17 Seikenkai Cultivation of a deodorizing lactobacillus strain, storage thereof, and composition containing living cells thereof
EP0101209A2 (en) * 1982-08-06 1984-02-22 Kabushiki Kaisya Advance Hypocholesterolemically and/or hypotriglyceridemically active products
EP0149579A2 (en) * 1984-01-17 1985-07-24 Laboratoires BIOCODEX Use of saccharomyces yeasts for the manufacture of a medicament for preventing or treating pseudo-membranous colitis
EP0181170A2 (en) * 1984-11-05 1986-05-14 Kabushiki Kaisya Advance Hypocholesterolemically active products
EP0195870A1 (en) * 1985-03-22 1986-10-01 Laboratoires BIOCODEX Use of saccharomyces yeast in the manufacture of a medicament against amoebiasis
GB2175804A (en) * 1985-05-29 1986-12-10 Dr Douglas Nelson Treating cramp
EP0208818A1 (en) * 1984-01-17 1987-01-21 Seikenkai Foundational Juridical Person Biodeodorizer and the process for the preparation thereof
US4710379A (en) * 1984-06-19 1987-12-01 Kabushiki Kaisya Advance Kaihatsu Kenkyujo Intestinal microflora-improving agent
EP0271364A2 (en) * 1986-12-12 1988-06-15 Biorem C.C. Preparation suitable for treating enteric disorders
US4812441A (en) * 1982-12-28 1989-03-14 Kabushiki Kaisya Advance Kaihatsu Kenkyujo Hypocholesterolemically active protein derived from streptococcus
US4824945A (en) * 1984-12-24 1989-04-25 Kabushiki Kaisya Advance Kaithatsu Kenkyujo Hypocholesterolemically active RNA fractions
EP0599479A2 (en) * 1992-11-24 1994-06-01 Institut Pasteur De Kyoto Lactobacillus used to enhance immunological functions
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
WO1999007393A1 (en) * 1997-08-05 1999-02-18 Rodica Teodorescu Pharmaceutical product comprising bacterial strains for the colon therapy
FR2826020A1 (en) * 2001-06-14 2002-12-20 Ceva Sante Animale Selecting strains of lactic acid bacteria, useful for controlling infections by pathogenic bacteria, based on adhesion to tissue, each other and determinants of the pathogen
WO2002103034A1 (en) * 2001-06-14 2002-12-27 Ceva Sante Animale Method of selecting non-pathogenic gram-positive lactic acid bacteria strains
FR2831555A1 (en) * 2001-10-29 2003-05-02 Ceva Sante Animale Selecting strains of lactic acid bacteria, useful for controlling infections by pathogenic bacteria, based on adhesion to tissue, each other and determinants of the pathogen
WO2003047358A1 (en) * 2001-12-03 2003-06-12 Fonterra Co-Operative Group Limited Cheese flavour ingredient and method of its production
FR2873720A1 (en) * 2004-07-28 2006-02-03 Inst Francais Textile Habillem PROCESS FOR TREATING SANDY COTTON
WO2006021965A1 (en) * 2004-08-23 2006-03-02 Bharat Biotech International Limited Eukaryotic based synergistic formulation for gastro-intestinal disorders
WO2006122965A1 (en) * 2005-05-18 2006-11-23 Dsm Ip Assets B.V. Compositions for enteral application of microorganisms

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4345032A (en) * 1976-05-21 1982-08-17 Seikenkai Cultivation of a deodorizing lactobacillus strain, storage thereof, and composition containing living cells thereof
US4335107A (en) * 1978-06-05 1982-06-15 Snoeyenbos Glenn H Mixture to protect poultry from salmonella
EP0101209A2 (en) * 1982-08-06 1984-02-22 Kabushiki Kaisya Advance Hypocholesterolemically and/or hypotriglyceridemically active products
US4797278A (en) * 1982-08-06 1989-01-10 Kabushiki Kaisya Advance Kaihatsu Kenkyujo Hypocholesterolemically and/or hypotriglyceridemically active products and their use
EP0101209A3 (en) * 1982-08-06 1985-08-07 Kabushiki Kaisya Advance Kaihatsu Kenkyujo Hypocholesterolemically and/or hypotriglyceridemically active products
US4812441A (en) * 1982-12-28 1989-03-14 Kabushiki Kaisya Advance Kaihatsu Kenkyujo Hypocholesterolemically active protein derived from streptococcus
EP0208818A1 (en) * 1984-01-17 1987-01-21 Seikenkai Foundational Juridical Person Biodeodorizer and the process for the preparation thereof
EP0149579A3 (en) * 1984-01-17 1986-03-05 Laboratoires Biocodex Use of saccharomyces yeasts for preventing or treating pseudo-membranous colitis
US4871539A (en) * 1984-01-17 1989-10-03 Seikenkai Foundational Juridical Person Biodeodorizer and process for preparing same
EP0149579A2 (en) * 1984-01-17 1985-07-24 Laboratoires BIOCODEX Use of saccharomyces yeasts for the manufacture of a medicament for preventing or treating pseudo-membranous colitis
US4710379A (en) * 1984-06-19 1987-12-01 Kabushiki Kaisya Advance Kaihatsu Kenkyujo Intestinal microflora-improving agent
EP0181170A2 (en) * 1984-11-05 1986-05-14 Kabushiki Kaisya Advance Hypocholesterolemically active products
EP0181170A3 (en) * 1984-11-05 1988-03-16 Kabushiki Kaisya Advance Kaihatsu Kenkyujo Hypocholesterolemically active products
US4824945A (en) * 1984-12-24 1989-04-25 Kabushiki Kaisya Advance Kaithatsu Kenkyujo Hypocholesterolemically active RNA fractions
EP0195870A1 (en) * 1985-03-22 1986-10-01 Laboratoires BIOCODEX Use of saccharomyces yeast in the manufacture of a medicament against amoebiasis
GB2175804A (en) * 1985-05-29 1986-12-10 Dr Douglas Nelson Treating cramp
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
EP0271364A3 (en) * 1986-12-12 1988-10-26 Biorem C.C. Preparation suitable for treating enteric disorders
EP0271364A2 (en) * 1986-12-12 1988-06-15 Biorem C.C. Preparation suitable for treating enteric disorders
AU624067B2 (en) * 1986-12-12 1992-06-04 Biorem C.C. Preparation suitable for use in the treatment of enteric disorders
EP0599479A2 (en) * 1992-11-24 1994-06-01 Institut Pasteur De Kyoto Lactobacillus used to enhance immunological functions
EP0599479A3 (en) * 1992-11-24 1995-04-05 Pasteur Inst Kyoto Lactobacillus used to enhance immunological functions.
WO1999007393A1 (en) * 1997-08-05 1999-02-18 Rodica Teodorescu Pharmaceutical product comprising bacterial strains for the colon therapy
WO2002103034A1 (en) * 2001-06-14 2002-12-27 Ceva Sante Animale Method of selecting non-pathogenic gram-positive lactic acid bacteria strains
FR2826020A1 (en) * 2001-06-14 2002-12-20 Ceva Sante Animale Selecting strains of lactic acid bacteria, useful for controlling infections by pathogenic bacteria, based on adhesion to tissue, each other and determinants of the pathogen
FR2831555A1 (en) * 2001-10-29 2003-05-02 Ceva Sante Animale Selecting strains of lactic acid bacteria, useful for controlling infections by pathogenic bacteria, based on adhesion to tissue, each other and determinants of the pathogen
WO2003047358A1 (en) * 2001-12-03 2003-06-12 Fonterra Co-Operative Group Limited Cheese flavour ingredient and method of its production
FR2873720A1 (en) * 2004-07-28 2006-02-03 Inst Francais Textile Habillem PROCESS FOR TREATING SANDY COTTON
WO2006018533A2 (en) * 2004-07-28 2006-02-23 Institut Francais Textile Habillement Sticking cotton treatment method
WO2006018533A3 (en) * 2004-07-28 2006-04-13 Inst Francais Textile Habillem Sticking cotton treatment method
EA011893B1 (en) * 2004-07-28 2009-06-30 Институт Франсез Текстиль Абийман Sticking cotton fibres treatment method
WO2006021965A1 (en) * 2004-08-23 2006-03-02 Bharat Biotech International Limited Eukaryotic based synergistic formulation for gastro-intestinal disorders
WO2006122965A1 (en) * 2005-05-18 2006-11-23 Dsm Ip Assets B.V. Compositions for enteral application of microorganisms
US8697126B2 (en) 2005-05-18 2014-04-15 Dsm Ip Assets B.V. Compositions for enternal application of microorganisms

Similar Documents

Publication Publication Date Title
GB930107A (en) Therapeutic oral preparation of micro-organisms
Lopitz-Otsoa et al. Kefir: A symbiotic yeast-bacteria community with alleged healthy capabilities
US4298619A (en) Production of foods and drinks containing bifidobacteria
CA2484639A1 (en) Composition and method to produce and use fermented hydrolyzed products of miocrobial metabolism
CN113652359B (en) Lactic acid bacteria freeze-dried powder, preparation method and freeze-dried protective agent thereof
US6056979A (en) Streptococcus Thermophilus strain, fermentation process using such strain and product obtained
CN208798645U (en) Chocolate product containing probiotics
JP5393463B2 (en) Use of gum arabic to improve the growth and survival of bifidobacteria
Turkmen Kefir as a functional dairy product
Gilliland The lactobacilli: milk products
Nogueira et al. Microbiological quality of Portuguese yogurts
CN111820287A (en) Preparation method of pure plant handmade yoghurt powder
CN1201673C (en) Method for preparing sweetish whole grain sour bean by means of multistrain fermentation method
CN110184191A (en) A kind of raising lactobacillus bulgaricus is stored at room temperature and the freeze drying protectant of anti-pressure ability and its application
PT1624761E (en) Method and inoculum for acidifying lactic fermentation
GB1197257A (en) Fermented Milk
FR2123295A1 (en) Fermented milk drink - with lactic acid bacteria and yeasts which do not ferment lactose
GB2228494A (en) Method of obtaining a bacterial ferment for medical-dietetic product
CN110129217A (en) A kind of method and application improving lactic acid bacteria heat resistance
JPS6447338A (en) Preparation of kefir-like dairy product
YAMANAKA et al. Studies on Utilization of Soybean Protein for Food Manufacturing Part II. Influence of soy milk added to skimmilk on the acidity and the hardness of curd produced by lactic acid bacteria for dairy use
CN109258899A (en) A kind of nougat and preparation method thereof rich in active probiotic
JP2920892B2 (en) Kefir-like fermented milk powder and method for producing the same
JPH029781B2 (en)
CS19091A3 (en) Process for preparing probiotic preparations for people and animalsnutrition